{"id":829088,"date":"2025-03-24T13:52:09","date_gmt":"2025-03-24T17:52:09","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/contact-levi-korsinsky-by-april-14-2025-deadline-to-join-class-action-against-merck-co-inc-mrk-2\/"},"modified":"2025-03-24T13:52:09","modified_gmt":"2025-03-24T17:52:09","slug":"contact-levi-korsinsky-by-april-14-2025-deadline-to-join-class-action-against-merck-co-inc-mrk-2","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/contact-levi-korsinsky-by-april-14-2025-deadline-to-join-class-action-against-merck-co-inc-mrk-2\/","title":{"rendered":"Contact Levi & Korsinsky by April 14, 2025 Deadline to Join Class Action Against Merck & Co., Inc. (MRK)"},"content":{"rendered":"
\n

NEW YORK, March 24, 2025 (GLOBE NEWSWIRE) — Levi & Korsinsky, LLP notifies investors in Merck & Co., Inc.<\/strong> (“Merck” or the “Company”) (NYSE: MRK) of a class action securities lawsuit.<\/p>\n

\n CLASS DEFINITION: <\/strong>The lawsuit seeks to recover losses on behalf of Merck investors who were adversely affected by alleged securities fraud between February 3, 2022 and February 3, 2025. Follow the link below to get more information and be contacted by a member of our team:<\/p>\n

\n https:\/\/zlk.com\/pslra-1\/merck-co-inc-lawsuit-submission-form?prid=137733&wire=3<\/a>\n <\/p>\n

\n MRK<\/strong> investors may also contact Joseph E. Levi, Esq. via email at\u00a0jlevi@levikorsinsky.com<\/a> or by telephone at (212) 363-7500.<\/p>\n

\n CASE DETAILS: <\/strong>According to the complaint, defendants provided investors with material information concerning Merck\u2019s expected revenue of $11 billion from sales of Gardasil by 2030. Defendants\u2019 statements included, among other things, confidence in Merck\u2019s purported ability to utilize successful consumer activation and education efforts on the benefits of Gardasil in order to drive demand and capitalize on eligible populations for vaccination, resulting in confidently optimistic reports and forecasts of Gardasil\u2019s growth in China. The full truth finally emerged on February 4, 2025, when Merck announced it would no longer achieve the long-forecasted $11 billion in sales of Gardasil by 2030, as it would cease shipments of Gardasil to China \u201cthrough at least midyear\u201d to facilitate a \u201crapid reduction of inventory.\u201d Defendants claimed this was necessitated by the continued over-inflation of overall channel inventories as demand in China for Gardasil had \u201cnot recovered to the level we had expected.\u201d Following this news, Merck\u2019s common stock declined dramatically. From a closing market price of $99.79 per share on February 3, 2025, Merck\u2019s stock price fell to $90.74 per share on February 4, 2025, a decline of more than 9% in the span of just a single day.<\/p>\n

\n WHAT’S NEXT? <\/strong>If you suffered a loss in Merck during the relevant time frame, you have until April 14, 2025<\/strong>\u00a0to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.<\/p>\n

\n NO COST TO YOU: <\/strong>If you are a class member, you may be entitled to compensation without payment of any out-of-pocket costs or fees. There is no cost or obligation to participate.<\/strong><\/p>\n

\n WHY LEVI & KORSINSKY: <\/strong>Over the past 20 years, the team at Levi & Korsinsky has secured hundreds of millions of dollars for aggrieved shareholders and built a track record of winning high-stakes cases. Our firm has extensive expertise representing investors in complex securities litigation and a team of over 70 employees to serve our clients. For seven years in a row, Levi & Korsinsky has ranked in ISS Securities Class Action Services\u2019 Top 50 Report as one of the top securities litigation firms in the United States.<\/p>\n

\n CONTACT:<\/strong>
\n
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
Ed Korsinsky, Esq.
33 Whitehall Street, 17th Floor
New York, NY 10004
jlevi@levikorsinsky.com<\/a>
Tel: (212) 363-7500
Fax: (212) 363-7171
www.zlk.com<\/a><\/p>\n

\"\"
\n
\n \"\"\n <\/div>\n

<\/div>\n","protected":false},"excerpt":{"rendered":"

NEW YORK, March 24, 2025 (GLOBE NEWSWIRE) — Levi & Korsinsky, LLP notifies investors in Merck & Co., Inc. (“Merck” or the “Company”) (NYSE: MRK) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Merck investors who were adversely affected by alleged securities fraud between February 3, 2022 and February 3, 2025. Follow the link below to get more information and be contacted by a member of our team: https:\/\/zlk.com\/pslra-1\/merck-co-inc-lawsuit-submission-form?prid=137733&wire=3 MRK investors may also contact Joseph E. Levi, Esq. via email at\u00a0jlevi@levikorsinsky.com or by telephone at (212) 363-7500. CASE DETAILS: According to the complaint, defendants provided investors with material information concerning Merck\u2019s expected revenue of $11 billion from sales of Gardasil by … <\/p>\n

Continue reading “Contact Levi & Korsinsky by April 14, 2025 Deadline to Join Class Action Against Merck & Co., Inc. (MRK)”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-829088","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nContact Levi & Korsinsky by April 14, 2025 Deadline to Join Class Action Against Merck & Co., Inc. (MRK) - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/contact-levi-korsinsky-by-april-14-2025-deadline-to-join-class-action-against-merck-co-inc-mrk-2\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Contact Levi & Korsinsky by April 14, 2025 Deadline to Join Class Action Against Merck & Co., Inc. (MRK) - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"NEW YORK, March 24, 2025 (GLOBE NEWSWIRE) — Levi & Korsinsky, LLP notifies investors in Merck & Co., Inc. (“Merck” or the “Company”) (NYSE: MRK) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Merck investors who were adversely affected by alleged securities fraud between February 3, 2022 and February 3, 2025. Follow the link below to get more information and be contacted by a member of our team: https:\/\/zlk.com\/pslra-1\/merck-co-inc-lawsuit-submission-form?prid=137733&wire=3 MRK investors may also contact Joseph E. Levi, Esq. via email at\u00a0jlevi@levikorsinsky.com or by telephone at (212) 363-7500. CASE DETAILS: According to the complaint, defendants provided investors with material information concerning Merck\u2019s expected revenue of $11 billion from sales of Gardasil by … Continue reading "Contact Levi & Korsinsky by April 14, 2025 Deadline to Join Class Action Against Merck & Co., Inc. (MRK)"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/contact-levi-korsinsky-by-april-14-2025-deadline-to-join-class-action-against-merck-co-inc-mrk-2\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-03-24T17:52:09+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM5ODk1MiM2ODE4NjAzIzIwMjA0MjY=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/contact-levi-korsinsky-by-april-14-2025-deadline-to-join-class-action-against-merck-co-inc-mrk-2\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/contact-levi-korsinsky-by-april-14-2025-deadline-to-join-class-action-against-merck-co-inc-mrk-2\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Contact Levi & Korsinsky by April 14, 2025 Deadline to Join Class Action Against Merck & Co., Inc. (MRK)\",\"datePublished\":\"2025-03-24T17:52:09+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/contact-levi-korsinsky-by-april-14-2025-deadline-to-join-class-action-against-merck-co-inc-mrk-2\\\/\"},\"wordCount\":492,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/contact-levi-korsinsky-by-april-14-2025-deadline-to-join-class-action-against-merck-co-inc-mrk-2\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM5ODk1MiM2ODE4NjAzIzIwMjA0MjY=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/contact-levi-korsinsky-by-april-14-2025-deadline-to-join-class-action-against-merck-co-inc-mrk-2\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/contact-levi-korsinsky-by-april-14-2025-deadline-to-join-class-action-against-merck-co-inc-mrk-2\\\/\",\"name\":\"Contact Levi & Korsinsky by April 14, 2025 Deadline to Join Class Action Against Merck & Co., Inc. (MRK) - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/contact-levi-korsinsky-by-april-14-2025-deadline-to-join-class-action-against-merck-co-inc-mrk-2\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/contact-levi-korsinsky-by-april-14-2025-deadline-to-join-class-action-against-merck-co-inc-mrk-2\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM5ODk1MiM2ODE4NjAzIzIwMjA0MjY=\",\"datePublished\":\"2025-03-24T17:52:09+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/contact-levi-korsinsky-by-april-14-2025-deadline-to-join-class-action-against-merck-co-inc-mrk-2\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/contact-levi-korsinsky-by-april-14-2025-deadline-to-join-class-action-against-merck-co-inc-mrk-2\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/contact-levi-korsinsky-by-april-14-2025-deadline-to-join-class-action-against-merck-co-inc-mrk-2\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM5ODk1MiM2ODE4NjAzIzIwMjA0MjY=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM5ODk1MiM2ODE4NjAzIzIwMjA0MjY=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/contact-levi-korsinsky-by-april-14-2025-deadline-to-join-class-action-against-merck-co-inc-mrk-2\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Contact Levi & Korsinsky by April 14, 2025 Deadline to Join Class Action Against Merck & Co., Inc. (MRK)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Contact Levi & Korsinsky by April 14, 2025 Deadline to Join Class Action Against Merck & Co., Inc. (MRK) - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/contact-levi-korsinsky-by-april-14-2025-deadline-to-join-class-action-against-merck-co-inc-mrk-2\/","og_locale":"en_US","og_type":"article","og_title":"Contact Levi & Korsinsky by April 14, 2025 Deadline to Join Class Action Against Merck & Co., Inc. (MRK) - Market Newsdesk","og_description":"NEW YORK, March 24, 2025 (GLOBE NEWSWIRE) — Levi & Korsinsky, LLP notifies investors in Merck & Co., Inc. (“Merck” or the “Company”) (NYSE: MRK) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Merck investors who were adversely affected by alleged securities fraud between February 3, 2022 and February 3, 2025. Follow the link below to get more information and be contacted by a member of our team: https:\/\/zlk.com\/pslra-1\/merck-co-inc-lawsuit-submission-form?prid=137733&wire=3 MRK investors may also contact Joseph E. Levi, Esq. via email at\u00a0jlevi@levikorsinsky.com or by telephone at (212) 363-7500. CASE DETAILS: According to the complaint, defendants provided investors with material information concerning Merck\u2019s expected revenue of $11 billion from sales of Gardasil by … Continue reading \"Contact Levi & Korsinsky by April 14, 2025 Deadline to Join Class Action Against Merck & Co., Inc. (MRK)\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/contact-levi-korsinsky-by-april-14-2025-deadline-to-join-class-action-against-merck-co-inc-mrk-2\/","og_site_name":"Market Newsdesk","article_published_time":"2025-03-24T17:52:09+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM5ODk1MiM2ODE4NjAzIzIwMjA0MjY=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/contact-levi-korsinsky-by-april-14-2025-deadline-to-join-class-action-against-merck-co-inc-mrk-2\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/contact-levi-korsinsky-by-april-14-2025-deadline-to-join-class-action-against-merck-co-inc-mrk-2\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Contact Levi & Korsinsky by April 14, 2025 Deadline to Join Class Action Against Merck & Co., Inc. (MRK)","datePublished":"2025-03-24T17:52:09+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/contact-levi-korsinsky-by-april-14-2025-deadline-to-join-class-action-against-merck-co-inc-mrk-2\/"},"wordCount":492,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/contact-levi-korsinsky-by-april-14-2025-deadline-to-join-class-action-against-merck-co-inc-mrk-2\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM5ODk1MiM2ODE4NjAzIzIwMjA0MjY=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/contact-levi-korsinsky-by-april-14-2025-deadline-to-join-class-action-against-merck-co-inc-mrk-2\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/contact-levi-korsinsky-by-april-14-2025-deadline-to-join-class-action-against-merck-co-inc-mrk-2\/","name":"Contact Levi & Korsinsky by April 14, 2025 Deadline to Join Class Action Against Merck & Co., Inc. (MRK) - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/contact-levi-korsinsky-by-april-14-2025-deadline-to-join-class-action-against-merck-co-inc-mrk-2\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/contact-levi-korsinsky-by-april-14-2025-deadline-to-join-class-action-against-merck-co-inc-mrk-2\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM5ODk1MiM2ODE4NjAzIzIwMjA0MjY=","datePublished":"2025-03-24T17:52:09+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/contact-levi-korsinsky-by-april-14-2025-deadline-to-join-class-action-against-merck-co-inc-mrk-2\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/contact-levi-korsinsky-by-april-14-2025-deadline-to-join-class-action-against-merck-co-inc-mrk-2\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/contact-levi-korsinsky-by-april-14-2025-deadline-to-join-class-action-against-merck-co-inc-mrk-2\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM5ODk1MiM2ODE4NjAzIzIwMjA0MjY=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM5ODk1MiM2ODE4NjAzIzIwMjA0MjY="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/contact-levi-korsinsky-by-april-14-2025-deadline-to-join-class-action-against-merck-co-inc-mrk-2\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Contact Levi & Korsinsky by April 14, 2025 Deadline to Join Class Action Against Merck & Co., Inc. (MRK)"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/829088","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=829088"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/829088\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=829088"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=829088"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=829088"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}